Overview
ANGELALIGN (6699)
Angelalign Technology Inc., an investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the Peo...
- Open
- 77.600
- High
- 79.900
- Low
- 77.550
- Prev. Close
- 78.500
- Volume
- 213.40K
- Turnover
- 16.90M
- Avg Price
- 79.171
- Bid/Ask Ratio
- 84.62%
- Amplitude
- 2.99%
- 52wk High
- 95.950
- Volume Ratio
- 0.25
- Turnover Ratio
- 0.12%
- 52wk Low
- 48.360
- HK Mkt Cap
- 13.77B
- Market CapHKD
- 13.77B
- P/ETTM
- 42.78
- P/EDynamic
- 32.22
- P/EStatic
- --
- EPSTTM
- 1.87
- EPSDynamic
- 2.48
- EPSStatic
- --
- BVPS
- 18.75
- P/B
- 4.26
- HK Shares
- 172.34M
- Dividend YieldTTM
- 12.49%
- DividendTTM
- 9.977
- Shares
- 172.34M
- Min lot size
- 200
- Currency
- HKD
ANGELALIGN Analyst Rating
View moreForecast & Rating
Oct 27, 2026- Strong buy80.00%
- Buy10.00%
- Hold10.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 8
- Buy
- 1
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
Daily Events
- Oct, 28
Angelalign gapped up to HK$81.40 and then slid through both sessions to a last price of HK$76.80, down 5.01%, after Align Technology won its patent case at the UPC and a Paris court found the company's Torque Ridges feature infringes Align's patent, triggering multi-country bans in Europe; management said the discontinued feature has minimal customer impact after the shift to Pressure Points. The move runs against strong fundamentals: Q2 2026 revenue of HK$904.7m rose 42.85% yoy, net profit HK$106.9m gained 85.93%, operating income HK$136.9m rose 257.1%, EPS HK$0.6274 climbed 84.3%, with ROE at 13.23%. At HK$76.80 the stock sits 23.2% below its 3 September 52-week high of HK$100 yet is still up 26.11% YTD, having fallen below MA20 of HK$81.76 and MA60 of HK$87.93, with PE 41.23x, market cap HK$13.27bn and turnover rate just 0.12%. Goldman Sachs and JPMorgan had added at roughly HK$81.85 and HK$85.54 respectively, though European patent enforcement remains an overhang.
- Sep, 11
Angelalign closed down 4.5% at HKD87.45, pressured by profit-taking after recent strong gains and negative sentiment from an Align Technology patent case loss; it opened at HKD91.6 quickly turned negative, extending afternoon losses to an intraday low of HKD85.65, closing at HKD87.45—still 12.55% below its 52-week high of HKD100 but 50.26% above its 52-week low of HKD58.2. The firm posted robust 1H26 results: revenue up 42.9% YoY to HKD904M, net profit up 79.6% to HKD107M, and operating profit surging 188%. Morgan Stanley raised its target from HKD90 to HKD105 (Equalweight), while CMBI upgraded its target to HKD114.21, citing above-consensus results. However, daily turnover was only HKD87M with a 0.58% turnover rate, suggesting selling pressure was orderly.
- Sep, 1
Angelalign Technology opened higher and closed up 5.72% at HKD 95.15, with the morning session's only trade at HKD 94.70 marking the intraday high and low, eventually finishing at the day's peak. The surge was driven by the company's robust FY26 H1 results, which showed revenue up 42.9% to approximately USD 230.7 million and net profit up 79.6% to USD 25.5 million, sending the stock surging over 21% earlier on the profit alert and hitting a 52-week high. YTD gain stands at 56.24%, yet the current price is still 4.61% below the 52-week high of HKD 99.75, while it has moved above both the 20-day MA (HKD 91.718) and 60-day MA (HKD 80.175). However, the company recently lost a patent case in China to Align Technology and plans to appeal, which has tempered sentiment.
- Aug, 24
Angelalign opened higher but retreated in morning trading, as the company's earlier profit alert projecting a H1 net profit increase of up to 79% was offset by the negative news of Align Technology winning a China patent lawsuit against the firm. The stock fell from an intraday high of 90.300 HKD to 88.950 HKD, down about 2.1% from the previous close of 90.900 HKD, yet still up over 46% YTD from its 2025 start of 60.9 HKD and about 10.8% below its 52-week high of 99.75 HKD. Q4 revenue rose 41.9% YoY to 812.7 million HKD and net profit climbed 54.4% YoY, though the intraday average price of 89.12 HKD remained below the 20-day MA of 90.42 HKD, suggesting near-term resistance.
- Aug, 4
Angelalign opened at HKD 94.25 and trended upward after a profit alert, hitting an intraday high of HKD 96.5 before closing at HKD 96.15, up 2.02%, nearing its 52-week high of HKD 97. The company guided 2026 H1 net profit of USD 24-25.4 million, up 69%-78.9% YoY, with Q4 2025 revenue climbing 41.89% YoY and EPS soaring 60.45% YoY, lifting net profit margin to 6.6%. Nomura subsequently raised its target price from HKD 92.22, adding momentum. However, the stock's YTD gain of 57.88% and a PE of 74.59x may cap near-term upside.
News
Simplywall · How New Aligner Material At Angelalign Technology Stock Has Changed Its Investment Story
Global Report · AI Bets and Overseas Breakthroughs: Hong Kong Small-Caps Redefine Growth Trajectories
Market Movers · Angelalign drops 8%
Weekly Review · Weekly Recap | ANGELALIGN +1.95%, most brokers rate it buy
prnewswire · Wyrok paryskiego sądu w sprawie wycofanej technologii bez większych konsekwencji dla klientów Angelalign
